Friday November 16, 2018 21:31

Heathcare Press Release : 16 Aug 2018

Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Heathcare—16 Aug 18

- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company's foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to